Jeffrey M. Jonas
2016
In 2016, Jeffrey M. Jonas earned a total compensation of $2M as President and Chief Executive Officer at Sage Therapeutics, a 80% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $315,900 |
|---|---|
| Option Awards | $1,175,332 |
| Salary | $486,000 |
| Other | $11,118 |
| Total | $1,988,350 |
Jonas received $1.2M in option awards, accounting for 59% of the total pay in 2016.
Jonas also received $315.9K in non-equity incentive plan, $486K in salary and $11.1K in other compensation.
Rankings
In 2016, Jeffrey M. Jonas' compensation ranked 4,913th out of 14,075 executives tracked by ExecPay. In other words, Jonas earned more than 65.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,913 out of 14,075 | 65th |
Division Manufacturing | 1,747 out of 5,489 | 68th |
Major group Chemicals And Allied Products | 547 out of 1,895 | 71st |
Industry group Drugs | 403 out of 1,538 | 74th |
Industry Pharmaceutical Preparations | 321 out of 1,176 | 73rd |
Source: SEC filing on April 27, 2018.
Jonas' colleagues
We found three more compensation records of executives who worked with Jeffrey M. Jonas at Sage Therapeutics in 2016.
News
Sage Therapeutics CEO Barry Greene's 2021 pay jumps 469% to $59M
April 28, 2022
Sage Therapeutics CEO Jeffrey Jonas' 2020 pay falls 53% to $4.7M
April 29, 2021
Sage Therapeutics CEO Jeffrey Jonas' 2019 pay rises 1% to $9.9M
April 29, 2020
Sage Therapeutics CEO Jeffrey Jonas' 2018 pay jumps 71% to $9.8M
April 25, 2019